HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop ...
Advancing Multiple Programs in Areas of Significant Unmet Medical Need Several Milestones Across Clinical Development Pipeline Expected in 2025 HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Bio-Path Hold ...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the launch of its new line of Endotoxin Free Silver Nanoparticles for biomedical research and ...
On December 27, 2024, the US Department of Justice (DOJ) issued a final rule establishing a new national security program to prevent access ...
Research shows 60% of missense mutations destabilize proteins, linking protein folding to genetic diseases, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback